PKCβ inhibitor 1
Modify Date: 2025-08-25 11:50:43
PKCβ inhibitor 1 structure
|
Common Name | PKCβ inhibitor 1 | ||
|---|---|---|---|---|
| CAS Number | 257879-35-9 | Molecular Weight | 411.45600 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H21N5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PKCβ inhibitor 1PKCβ inhibitor 1 is a potent, ATP-competitive, and selective PKCβ inhibitor with IC50s of 21 and 5 nM for human PKCβ1 and PKCβ2, respectively. PKCβ inhibitor 1 exhibits selectivity of more than 60-fold in favor of PKCβ2 relative to other PKC isozymes (PKCα, PKCγ, and PKCε)[1][2]. |
| Name | 3-anilino-4-[1-(3-imidazol-1-ylpropyl)indol-3-yl]pyrrole-2,5-dione |
|---|---|
| Synonym | More Synonyms |
| Description | PKCβ inhibitor 1 is a potent, ATP-competitive, and selective PKCβ inhibitor with IC50s of 21 and 5 nM for human PKCβ1 and PKCβ2, respectively. PKCβ inhibitor 1 exhibits selectivity of more than 60-fold in favor of PKCβ2 relative to other PKC isozymes (PKCα, PKCγ, and PKCε)[1][2]. |
|---|---|
| Related Catalog | |
| Target |
human PKCβ1:21 nM (IC50) human PKCβ2:5 nM (IC50) PKCα:331 nM (IC50) |
| In Vitro | PKCβ inhibitor 1 (0-30 μM; 48 hours) suppresses tumor cell proliferation in a time- and dose-dependent manner[2]. PKCβ inhibitor 1 (14 μM; 2-48 hours) induces apoptosis in 2F7 cells[2]. PKCβ inhibitor 1 (15 μM; 2-48 hours) inhibits cell cycle progression in 2F7 and BCBL-1 cells[2]. PKCβ (15 or 14 μM, respectively; 2-48 hours) inhibitor 1 reduces the expression of phospho-PKCβ in BCBL-1 and 2F7 cells[2]. PKCβ inhibitor 1(0-48 hours) suppresses GSK3β, mTOR, and S6 phosphorylation[2]. Cell Proliferation Assay[2] Cell Line: 2F7, BCBL-1 cells Concentration: 0, 5, 10, 20, and 30 μM Incubation Time: 48 hours Result: A dose-dependent reduction in viability of the 2F7 and BCBL-1 cells starting at 5 μM and increasing with elevated inhibitor concentration. Apoptosis Analysis[2] Cell Line: 2F7 cells Concentration: 14 μM Incubation Time: 2-48 hours Result: Apoptotic induction in 2.1% of the 2F7 cells above background after 2 hours of treatment, increasing through 48 hours of treatment. Cell Cycle Analysis[2] Cell Line: BCBL-1 Cells Concentration: 15 μM (the IC50) Incubation Time: 2-48 hours Result: Inhibits cell cycle progression in 2F7 and BCBL-1 cells. Western Blot Analysis[2] Cell Line: BCBL-1 and 2F7 cell lines Concentration: 15 or 14 μM (at the IC50 respectively) Incubation Time: 2-48 hours Result: The expression of phospho-PKCβ in BCBL-1 and 2F7 cells reduced. |
| References |
| Molecular Formula | C24H21N5O2 |
|---|---|
| Molecular Weight | 411.45600 |
| Exact Mass | 411.17000 |
| PSA | 84.44000 |
| LogP | 3.75660 |
| IN1136 |
| HMS3229K09 |
| PKCbeta Inhibitor |